Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.20.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Fair Value of Options Estimated on Date of Grant Using Black-Scholes Option Pricing Model Under the 2019 Plan, the fair value of the Baudax Bio options was estimated on the date of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

 

 

June 30,

 

 

 

2020

 

Range of expected option life

 

6 years

 

Expected volatility

 

73.75%

 

Risk-free interest rate

 

.42%

 

Expected dividend yield

 

 

—

 

 

Under the Recro Plan for the six months ended June 30, 2019, the fair value of the options granted to employees of the Company was estimated on the date of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

 

 

 

June 30,

 

 

 

2019

 

Range of expected option life

 

6 years

 

Expected volatility

 

79.96%

 

Risk-free interest rate

 

2.60%

 

Expected dividend yield

 

 

—

 
Summary of Stock Option Activity

The following table summarizes Baudax Bio stock option activity during the six months ended June 30, 2020:

 

 

 

Number of

shares

 

 

Weighted

average

exercise

price

 

 

Weighted

average

remaining

contractual life

Balance, December 31, 2019

 

 

643,879

 

 

$

6.33

 

 

9.9 years

Granted

 

 

816,299

 

 

 

3.50

 

 

 

Balance, June 30, 2020

 

 

1,460,178

 

 

$

4.75

 

 

9.7 years

Vested

 

 

80,479

 

 

$

6.33

 

 

9.4 years

Vested and expected to vest

 

 

1,460,178

 

 

$

4.75

 

 

9.7 years
Summary of RSUs Activity

The following table summarizes the Baudax Bio RSUs activity during the six months ended June 30, 2020:

 

 

Number of

shares

 

Balance, December 31, 2019

 

 

1,380,030

 

Granted

 

 

331,351

 

Vested and settled

 

 

(50,240

)

Balance, June 30, 2020

 

 

1,661,141

 

Expected to vest

 

 

1,661,141